The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide

Published: April 16 2025
Abstract Views: 1072
PDF: 306
Appendix: 284
Appendix: 284
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Cardiology Department, ULSSM, Cardiovascular Center of the University of Lisbon, Portugal.
Department of Cardiology (CVK) of German Heart Center Charité; German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany.
Division of Cardiovascular Medicine, The Ohio State University College of Medicine, Columbus, OH, United States.
Department of Cardiology, Royal Brisbane and Women’s Hospital and University of Queensland Faculty of Medicine, Brisbane, QLD, Australia.
Baylor Scott and White Research Institute, Dallas, TX; University of Mississippi, Jackson, MS, United States.
Max Super Specialty Hospital, New Delhi, India.
Heart Research Institute, Sydney, NSW, Australia.
Translational Medicine Academy, Basel, Switzerland.
Midwest Cardiovascular Institute, Naperville, IL, United States.
Translational Medicine Academy, Basel, Switzerland.
National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece.
Preventive Cardiology, Barbra Streisand Women’s Heart Center, Preventive and Cardiac Rehabilitation Center, Smidt Heart Institute, Los Angeles, CA, United States.
Velocity Clinic at Medical City Dallas, Univ. of Texas Southwestern Medical Center, Dallas, TX, United States.
Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, CA, United States.
St. Michael’s Hospital, University of Toronto, Canada.
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
Peking Union Medical College, Beijing, China.
Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
1. Murad MH. Clinical practice guidelines: a primer on development and dissemination. Mayo Clin Proc 2017;92:423-33. DOI: https://doi.org/10.1016/j.mayocp.2017.01.001
2. Guerra-Farfan E, Garcia-Sanchez Y, Jornet-Gibert M, et al. Clinical practice guidelines: The good, the bad, and the ugly. Injury 2023;54:S26-9. DOI: https://doi.org/10.1016/j.injury.2022.01.047
3. Boriani G, Venturelli A, Imberti JF, et al. Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022. Eur J Intern Med 2023;114:1-14. DOI: https://doi.org/10.1016/j.ejim.2023.04.020
4. Liang L, Bernhardsson S, Vernooij RW, et al. Use of theory to plan or evaluate guideline implementation among physicians: a scoping review. Implement Sci 2017;12:26. DOI: https://doi.org/10.1186/s13012-017-0557-0
5. Kastner M, Bhattacharyya O, Hayden L, et al. Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review. J Clin Epidemiol 2015;68:498-509. DOI: https://doi.org/10.1016/j.jclinepi.2014.12.013
6. Wang T, Tan JB, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open 2023;13:e062158. DOI: https://doi.org/10.1136/bmjopen-2022-062158
7. Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol 2018;72:351-66. DOI: https://doi.org/10.1016/j.jacc.2018.04.070
8. Tromp J, Ouwerkerk W, Teng TK, et al. Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. Eur Heart J 2022;43:2224-34. DOI: https://doi.org/10.1093/eurheartj/ehac103
9. Cader FA, Banerjee S, Gulati M. Sex differences in acute coronary syndromes: a global perspective. J Cardiovasc Dev Dis. 2022;9:239. DOI: https://doi.org/10.3390/jcdd9080239
10. Prasad SB, Atherton JJ. Learning from our differences: insights from a global heart failure registry. Lancet Global Health 2024;12:E344-5. DOI: https://doi.org/10.1016/S2214-109X(23)00593-4
11. Zieroth S, Saldarriaga Giraldo CI, Pinto F, et al. Applicability of heart failure clinical practice guidelines in low- and middle-income countries. Eur J Heart Fail 2025;27:435-41. DOI: https://doi.org/10.1002/ejhf.3485
How to Cite
Copyright (c) 2025 the Author(s)


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.